Memantine 10 mg Tablets is included in the Pill Pass Discount Drug List at Pill Pals Pharmacy. This educational article summarizes key FDA-label topics for patients, caregivers, and prescribers who want a plain-language overview before speaking with a physician or pharmacist.
Drug Name
Memantine 10 mg Tablets
FDA Labeled Indications
Memantine is FDA-labeled for the treatment of moderate to severe dementia of the Alzheimer's type.
Contraindications
Contraindications include hypersensitivity to memantine.
Warnings
Warnings include caution in conditions that raise urine pH, seizure disorder considerations, and dosing adjustment in severe kidney impairment.
Precautions
Use caution with kidney impairment, seizure history, urinary tract changes, sodium bicarbonate or carbonic anhydrase inhibitors, and other NMDA antagonists.
Adverse Reactions
Adverse reactions may include dizziness, headache, confusion, constipation, cough, high blood pressure, and sleepiness.
Pill Pass Discount Drug List Notes
Availability, quantity limits, manufacturer selection, and final dispensing decisions may depend on prescription requirements, clinical appropriateness, inventory, and applicable law. This article is informational and is not a substitute for individualized medical advice, diagnosis, treatment, or the full FDA-approved labeling for the dispensed product.
Related Pill Pass Discount Drug List Articles
For related medications on the same Pill Pass Discount Drug List, you may also review Memantine 5 mg Tablets, Metformin 500 mg Immediate Release Tablets, Metformin 1,000 mg Immediate Release Tablets, and Lovastatin 20 mg Tablets.
Source note: this article is written as a patient-friendly summary of FDA labeling topics available through DailyMed and related FDA labeling resources. Manufacturer-specific labeling can vary, so patients should rely on the medication guide, package insert, prescriber instructions, and pharmacist counseling for their specific product.
Memantine 10 mg Tablets is on the Pill Pass List. This information is accurate as of May 13, 2026. If you would like more information on this medication, please contact your Physician or Pharmacist.
